Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions

Clinical trial NCT07090525 · RECRUITING

Trial details

NCT number: NCT07090525
Sponsor: Qingdao Central Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Overall Response Rate

Start date: 2025-07-01
Primary completion: 2026-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.